Mivell is an innovative company that, through its know-how and network, develops nutraceutical formulations characterized by high scientific value and therapeutic specificity, serving as complementary solutions to traditional therapies for chronic diseases. The company offers licensing-out opportunities for a newly developed and patented formulation (Patent No. EP 4 205 733) for treating osteopenia and osteoporosis, with published clinical results demonstrating the product's ability to promote osteogenesis.
No comments available.
Leave your rating & comment